AngioDynamics (NSDQ:ANGO) CEO Jim Clemmer said the company is actively walking the M&A trail as it looks at markets with unmet needs and high margins.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,